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Cell-mediated cytotoxicity measurements can be divided in two methods, depending on whether radioactive material is used or not. Natural 
Killer cell-mediated cytotoxicity is routinely measured with a short-term assay by labeling the target cells with radioactive chromium (51Cr). 
The advantages of this method are (1) highly sensitivity, (2) easy execution, (3) low spontaneous release, and (4) nontoxic markers. The 
disadvantages include short half-life of the label and handling and disposal of radioactive supplies. Many attempts have been made to adapt 
this cytotoxicity assay to abolish radioactivity while maintaining its high sensitivity. Consequently, various nonradioactive methods have been 
developed. One of these methods utilizing the release of enzymes (LDH) as a result of cytolysis or membrane dyes (PKH-26) is usually less 
sensitive than radioactive assays. MTT-based colorimetric/enzymatic assays are highly sensitive and easy to use but unfortunately works only 
with adherent tumor cell targets. Fluorescent dyes such as carboxy-fluorescein diacetate can easily accumulate in the cytoplasm of effector or 
target cells. After cytotoxicity, the release of the dyes into the supernatant or their retention in target cells is calculated. However, spontaneous 
release of these dyes can be quite high, causing false positive results leading to a decreased sensitivity and restricting their use in short-term 
assays. More recently, flow cytometric methods using fluorescent monoclonal antibodies such as anti-CD56 for effector and anti-CD33 for 
target cells have been defined.
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INTRODUCTION
In this review, we first define cell-mediated cytotoxicity. 
Cytotoxicity describes the realization of target cell death 
by mechanisms causing apoptosis/necrosis through 
mediators of the effector cell and/or membrane receptors 
(1). There are two general methods for the measurement 
of target cell death (cytolysis) described in the literature. 
One is based on radioactive material whereas the other 
is based on nonradioactive material. Two different main 
methods include the use of radioactive and nonradioactive 
enzymatic, membrane/fluorescent dyes and flow 
cytometry. Cell-mediated cytotoxicity measurement are 
mostly based on the presence of Natural Killer cells (NK) 
which play a role in the diagnosis of certain immunological 
and hemophagocytic disorders(2).
NK cells obtained from peripheral blood and NK cell 
l ines derived from tumor cells (KHYG-1, NK-92 and 
YT cell lines) are used as effector cells to evaluate cellular 
cytotoxicity. Unconjugated peripheral blood mononuclear 
cells are also used to measure peripheral blood NK cell 
cytotoxicity (3,4). Cells such as unconjugated CD8+-CTL 
(cytotoxic T lymphocyte) cells or CTL cell line AJY can 
also be used against different target cells (5). Effector cells 
are stimulated with specific cytokines such as IL-2 and/or 
IL-15, and transformed into lymphokine-activated killer 
(LAK) cells to evaluate cytotoxicity tests (6).
NK and CTL are the main cells of the natural and 
adaptive immune response. NK cells are predominant 
in defending against target cells that are infected with 
virus or that lose major histocompatibility complex class 
I (MHC-I) expression such as malignant cells. CTL cells 
function with at least three signals to generate response 
of the adaptive system. However, both cells function 
by containing cytolytic granules (7). Development of 
cytotoxicity due to cell-contact is a determining factor 
for CTL and NK cells. In vitro cytotoxicity studies have 
identified two major mechanisms of contact. The first 
is based on the activation of pathways leading to lysis in 
the target cell by discharging the lytic granules in the cell 
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such as pore-forming perforin and pro-apoptotic serine 
proteases (granzymes). The second is that the effector cell 
stimulates apoptosis-inducing receptors in the target cell 
such as TNF family member, TNF-α, Fas ligand (FasL), or 
TRAIL (tumor necrosis factor-related apoptosis-inducing 
ligand) (7). Cell lines such as NK-sensitive tumor cells K562 
(human chronic myeloid leukemia cell line) and YAC-1 
(lymphoma), are used as target cell types in evaluating 
cellular cytotoxicity (8). NK-resistant/LAK-sensitive: Raji 
and Daudi (derived from Burkitt’s lymphoma) cell lines 
are used. Other used leukemia cell lines are EM-2 (KML), 
EM-3 (KML), Jurkat, THP-1, HL60 (AML), U937 (9).
This review discusses the advantages and disadvantages 
of radioactive and non-radioactive methods for the 
measurement of cytotoxicity and will go in more detail 
regarding the non-radioactive methods.
RADIOACTIVE ASSAYS
Chromium (51Cr) Release Assay: CRA
CRA was first described by Brunner et al. in 1968 (10) 
and is the the gold standard and most popular method. 
This assay is based on measurement of the release of 
radioactive 51Cr - Na2 51CrO4 loaded into the target 
cell after lysis during in vitro evaluation of cell-mediated 
cytotoxicity. The advantages are that the test is easy to 
conduct and very reproducible (11). The radioactive or 
non-radioactive assays used to measure cytotoxicity are 
compared with CRA, which is the gold standard test, and 
the correlation between them is examined
Disadvantages / Limitations
51Cr is radioisotope and a volatile element which 
requires license for storage and waste and needs control 
(12,13). Hence it is expensive and has a short half-life. 
Target cell with slow metabolism is slow or a low cytoplasm/
nucleus ratio is hard to label. CRA delays in reflecting the 
damage/death in the cell and it measures at cell collection 
level rather than target single cell. It is time consuming to 
label the target cells and requires large number of target 
cells. Around 15% spontaneous release from the target cell 
can occur especially in long-term tests (5).
JAM (Jurkat Apoptosis Measurement) Test 
Matzinger et al. developed an alternative radioactive 
method to measure cytotoxicity based on measuring 
apoptosis in Jurkat cell lines (14). The JAM Test is a 
method that measures the DNA fragmentation with 
labeled triitium [3H] methyl-thymidine. Target cell death 
is quantified by measuring the release of labeled DNA 
particles. It is considered as a quantitative radioactive assay 
that measures apoptosis in the target cell. Radioactivity can 
be seen as a disadvantage. However, compared to CRA, it 
has advantages of being cheaper, easier, more sensitive and 
reliable (15).
NON-RADIOACTIVE ENZYMATIC ASSAYS
These assays are based on the fact that the target cell 
releases enzymes that are related to apoptosis or cell 
damage.
Lactate Dehydrogenase (LDH )Release Assay
The LDH Release assay was first identified by 
Korzenniewski and Callewaert in 1983 (16). It is based on 
the fact that LDH is released from lysed target tumor cells. 
The amount of LDH released into medium is proportional 
to the number of dead cells. Ready-to-use measurement 
kits are commercially available (17). A major disadvantage 
of this test is that intact cells can re-uptake the released 
LDH. Advantages are it correlates with CRA, is sensitive, 
and easy to conduct.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2Htetrazolium bromide) Colorimetric Assay
This assay is used in research laboratories to measure 
the sensitive/resistant of tumor cells to chemotherapeutic 
agents. The MTT assay is a colorimetric assay that relies 
on the mitochondrial enzyme dehydrogenase to convert 
tetrazolium dye MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide to formazon which than 
can be quantified by spectrophotometric means (18). 
The production of formazan is directly proportional to 
the number of live cells. At the end, NK cytotoxicity is 
measured against K562 tumor cell in vitro. Besides being 
reliable and well correlated with CRA, it is easy to conduct, 
and sensitive; it is also possible to measure cytotoxicity 
in multiple small wells with different effector/target 
cell ratios. The disadvantage is that this test can only be 
performed with adherent cells (19).
Granzyme B ELISPOT Test
This test is based on the measurement of  serine 
esterase level in cytotoxic cells of CD8+- CTL, and NK 
cell. Granzim B enzyme level increases with stimulation 
that occurs in the cytotoxic cell encountering with the 
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target cell. A special kit has also been developed for this 
method (20). It is reliable, correlated with CRA, and easy 
to conduct. On the other hand, it has a disadvantage of 
reflecting capacity of cytotoxic cell rather than an actual 
cytolysis.
NON-RADIOACTIVE FLUORESCENT       
MARKING ASSAYS
Due to inefficiencies or difficulties in radioactive and 
non-radioactive assays, new assays have been developed 
using non-radioactive fluorescent dye assays or target cell 
marking techniques with monoclonal antibodies and their 
utilization in flow cytometer. 
General Properties of Flow Cytometric Assays 
No standard or routine flow cytometer assay are 
available yet. However, a lot of clinical and research centers 
have developed their own methods and determined the 
validity of according to chromium release assay, which is 
considered as the golden standard.
Flow cytometer assays have the ability to perform 
single, double, and multi-colored methods (1). Singlecolor 
flow cytometer assays are based on light scattering 
characteristics of cell (Figure 1). Flow cytometer assay 
measure the target cell death (cytotoxicity) by staining 
the membrane or DNA of the target cell with different 
fluorescent dye or mAb. 
Examples of Membrane Staining with Fluorescent 
Substances
Examples of cytotoxicity measurements based on 
membrane staining techniques with some fluorescent 
substances will be introduced here.
Fluorescent Bound to Lipophilic Membrane
F-18 (octadecylamine- fluorescein isothiocyanate), 
PKH-2, PKH-26, Europium (Eu3+), and MitoTracker 
Green (MTG) are fluorescent Lipophilic dyes that will bind 
to membranes are used to measure cytotoxicity. These are 
usually green and red fluorescent dyes that mark target and 
effector cells. Membrane fixation is needed for dyes such 
as PKH-26 and DiOC18  however, its effect on cytotoxicity 
during co-incubation is not clear (5,9,11,21-24).  This 
technique is easy to use, sensitive, and reliable; but leakage 
of these dyes from cells is a significant disadvantage.
Carboxy-Fluorescein Diacetate
(CFSE: carboxyfluorescein succinimidyl ester)
This assay is based on measurement of dye release by 
microflorimeter after membrane staining and cytolysis. A 
high rate of release leads to incorrect results in short-term 
experiments (25).
DNA Staining Assays with Fluorescent Substance
Aminoactinomycin (7-AAD), PI (propidium iodide), 
CAM (Calcein-AM: calcein acetoxymethyl ester), and 
TO-PRO-3 iodide etc. are substance that will stain DNA 
in target cell and reflect cell death.  PI and PKH-26 are 
red fluorescent dyes whereas PKH-2, F-18, CAM, DIOC18 
(D275) are green fluorescent dyes (21-27). First, 7-AAD 
and PI were used frequently in the beginning (25,26), 
but CAM has become more prominent recently. The 
disadvantage of this method is that leakage can occur. 
Advantages for this method are DNA staining assays with 
fluorescent substance are easy to apply, sensitive, and 
reliable. They are also successful especially in long-term 
(over 4 hours) cytotoxicity tests (27).
CAM (Calcein-AM: calcein acetoxymethyl ester)
It is a DNA dye used for effector and target cell staining. 
Spontaneous release after incubation and difficulty of 
loading are noteworthy, even at lower rates than others 
(27).
Red / Green Fluorescent Dyes
PI and PKH-26 of membrane and DNA markers are 
red fluorescent dyes. PKH-2, F-18, CAM, DIOC18 (D275) 
are known as green fluorescent dyes (21-27).
Monoclonal Antibody Marking of Target and 
Effector Cell in Flow Cytometry
The fluorescent monoclonal antibody (mAb) effector 
bound to membrane is used in the selection and marking 
of target cell and conjugation (adhesion of the effector cell 
to the target). The monoclonal antibodies used to mark the 
effectors are anti-CD2, anti-CD5, anti-CD7, anti-CD16, 
and anti-CD56 (8,9). The monoclonal antibodies used to 
mark the target cells are anti-CD19, anti-CD33, and anti-
CD58. AnnexinV (AnnV) is used to measure apoptosis in 
the target cell; and 7- AAD or PI for necrosis (28-30).
We will briefly introduce our assay below as an 
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Our Assay: Flow Cytometric Cell-Mediated 
Cytotoxicity Assay
This is a three color flow cytometric assay. Target and 
effector cells are differentiated by specific fluorochrome-
conjugated mAb staining. The anti-CD33-PE 
fluorochrome dye is used for K-562 target cell staining and 
anti-CD19-PE  is used for Daudi or Raji cells (8). 
During the development of this assay, anti-CD2-PE, 
anti-CD5-PE, anti-CD7-PE mAb were used for effector 
staining during development of this assay. Anti-CD2-PE 
was the most successful mAb. Annexin V (AnnV) / propium 
iodid (PI) is introduced to medium after co-incubation to 
measure target cell death (Figure 2,3). Absolute apoptotic/
necrotic cell death counts are calculated with the help of 
fluorescent beads: fluorosphere numbers. Calibration and 
absolute number (not %, cumulative death) are measured 
with fluorosphere (8). 
The main advantage of our assay is the lack of dye 
leakage problem and cell membrane fixation. Target 
cell and conjugation populations are selected and death 
is calculated directly by our assay. It is very effective 
in short time (≤4 hours) as well as long-term (≤24 
hours) cytotoxicity measurements. Hence, this assay 
Figure 1. In the initial flow cytometric cell-mediated cytotoxicity studies, target and effector cells were distinguished by taking into account 
the light scattering characteristics of cells (such as SSC: granulation). The target cell K562 and the conjugate (effector bounds to target) 
population are located above the histogram and the effector peripheral blood lymphocyte is located below; clear distinction is observed. In 
the histogram; R1, R2, R3 fields are in the first, second and third regions. Representative distribution of target (R1) and effector (R2) cells 
(first alone then co-incubated), and conjugated (where the effector bounds to the target: R3 field) can be seen in histogram. In this method, 
cytotoxicity was calculated by measuring death in target cells after co-incubation and target cells in conjugate with fluorescent dyes such 
as PI, 7-AAD, AnnV in target cells in target cells and conjugate after co-incubation (adapted from reference 34). 
also measures early apoptosis and necrotic death, and 
correlates well with CRA (≥90%) (8,15,35). This assay 
can still be applied by changing effector or target cell, 
that is, using different effectors (mast cells) and target 
tumor cells (Daudi, Raji, U937, HLA, Meg-01 etc.) (31-
33). It is open for multiparametric applications (different 
metabolic changes in cells other than death) at the same 
time in future. Another advantage is the fact that it can 
evaluate cumulative measurement rather than instant 
cross-sectional (34,35).
Target and effector cells are differentiated by specific 
fluorochrome-conjugated mAb staining. This method 
allows also for mast cells to be used as effectors instead of 
NK and LAK cells (6,31). If leukemia group tumor cells 
are used as target cells, anti-CD33-PE mAb is the most 
suitable antibody (Figure 2,3).
Starting from very low (½:1) E (effector):T (target 
cell) ratios, our assay was observed to give accurate and 
correlated results with CRA up to 128:1 or 256:1. We 
have also shown that cytotoxicity increases in parallel to 
increasing E:T ratios (8).
This assay also measured the cytotoxicity more 
successfully than other assays in short-term and long-term 
incubations of ½ to 18- 24 hours (36).
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In the cross-sectional ‘percent cytotoxicity’ calculation, 
the target cell death (cytotoxicity) is calculated. The rate 
of live cells in control is first found by subtracting the 
spontaneous death from the total number of cells in the 
control. It can be formulated as %cytotoxicity= [Control 
live cell (%)-Co-incubation live cell (%)]/ %Control 
live cell. In measurement of ‘cumulative cytotoxicity’, 
the above-mentioned ratios are calculated based on 
absolute numbers determined by fluorosphere. Most of 
the flow cytometer studies are insufficient to show cell 
concentration and absolute cell numbers. Fluorospheres 
(cell counting beads) have been developed to fill this gap 
(8,31).
Cytotoxicity Assay by Measuring Expression 
Change / Degranulation with Fluorescent 
Monoclonal Antibody in Effector Cell Membrane in 
Flow Cytometry
Effector cell in flow cytometry is also marked by 
lipophilic dye attaching to membrane or entering into the 
cell. Thus, the effector cell is also marked and separated 
from the target cell and death measurement can be made 
by gating to the target.
Effector cell is measured by the expression of 
degranulation molecules (LAMP1/ CD107a) and it is 
marked with anti-CD56 mAb. The effector NK, which 
responds to stimulation occurs after encountering with 
the target tumor cell, indicates the percentage of cells. 
However, there has been debate about whether this 
method actually reflects the cytolysis in the target cell 
correctly (37).
CD107a is considered to be a reliable marker of NK cell 
cytotoxicity, but may also be useful in detailed evaluation 
of NK cell functions. Although whole blood is used in the 
previously mentioned method, cell culture laboratories are 
not required as the cell line is not used. This test requires 
low amount of whole blood, minimal time and iis cost 
effective.  Hence this test can be applied in routine clinic 
labs where flow cytometry is available (37).
Measurement of NK cell cytotoxicity is necessary when 
NK cell numbers and functions are impaired (classical 
or functional NK cell deficiencies). Genetic mutations 
that result in impaired or decreased NK cell and NK cell 
subgroup numbers are associated with more than 50 
primary immunodeficiency diseases (38).
Lymphohistiocytosis type 2 disease, which is one of the 
immune regulation disorders can be diagnosed by adding 
intracellular perforin staining into our test. This method is 
also helpful in differentiation of type 3 and type 4 disease 
having defective granule release mechanism, Griscelli 
syndrome, and Chediak-Higashi syndrome from acquired 
lymphohistiocytosis disease (37).
Figure 2. According to antibody bound and light scattering characteristic of fluorescent monoclonal anti-CD2 PE specific to target 
cell used in flow cytometry (FS: size); distinction of effector (E field), target cell (T field), and cells showing conjugation after the co-
incubation (effector is bound to target) (C field) can be seen in histogram. The effector cells appear below, the target and conjugate cells 
appear above (adapted from reference 9).
Target Cell Co-IncubationEffector Cell
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Enzymatic (fluorogenic caspase substrate) Assay 
Measuring Apoptosis with Fluorescent Dye in 
Target Cell in Flow Cytometry
As mentioned above; membrane dye AnnV, which 
is bound to phosphatidylserine displacing outwardly in 
target cell membrane leading to apoptosis, is commonly 
used to measure apoptosis. Furthermore, an enzymatic 
method for measuring apoptosis in target cell has also been 
described. By this method; measurement of the apoptotic 
process beginning in CTO (cell tracker orange)-stained 
target cell after co-incubation with effector cell in C57BL/6 
mice, is indicated by fluorescent staining (fluorogenic 
caspase substrate) indicating activation in the caspase 
enzyme. As is known, caspase is the first enzymatic (early 
apoptosis) component of pathway that induces apoptosis. 
It is claimed that this method measures apoptosis faster, is 
more sensitive, safer, and at a single cell level rather than 
population level (39). There are some disadvantages of 
this assay such as being triggered by various stimuli and 
questions about whether apoptosis starting with caspase 
will always result in death.
General Disadvantages of Flow Cytometric Assays
Fluorescent dyes may alter the sensitivity of target 
cell to cytotoxicity. Also most flow cytometric assays are 
based on the increase in membrane permeability of the 
target cell. This could cause artifacts due to leakage during 
incubation. Furthermore, fluorescent signal of some dyes 
are at low density, it may cause difficulty in detecting 
cytotoxicity (Table I) (3-5,11,15,22,23).
BRIEF COMPARISON OF CELL-MEDIATED 
CYTOTOXICITY ASSAYS
Although radioactive methods are still considered 
as the golden standard, advanced flow cytometric assays 
will become more utilized in the near future (Table I). 
Figure 3. According to antibody bound and light scattering characteristic of fluorescent monoclonal anti-CD19 PE specific to target cell 
used in flow cytometry (FS: size); distinction of effector (E field), target cell (T field), and conjugation (effector is bound to target) cells 
can be seen in above histograms. Conjugating cells are collected in the target cell population (the first stage of co-incubation) and at the 
bottom with the progression of co-incubation. The first graphs below is gated to effector (E field), the second to target (T) population, 
and the third again to T population. In the histograms below; effector, target, and conjugated target cell death can be evaluated with 
annexin V/PI dyes. In the histograms below, R1 refers to necrotic (AnnV- / PI+), R2 refers to late apoptotic (AnnV+/ PI+), R4 refers to 
early apoptotic (AnnV+ / PI-), and R3 refers to live cells (AnnV- / PI-). It is inferred that liveliness in the target cell after co-incubation 
decreased from 93% to 68%. (Adapted from reference 9).
Effector Cell Target Cell Co-Incubation
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Fluorescent mAbs markers are mostly used for target 
and effector cells because staining with these mAb occurs 
after-incubation prohibiting potential false positive 
results on cytotoxicity due to membrane fixation (3-
5,8,9,11,15,22,23). Table 1 presents comparison of all 
assays within/to each other.
FUTURE EXPECTATIONS: 
MULTI-COLOR FLOW CYTOMETRIC ASSAY, 
MULTIPARAMETRIC ASSAYS AND IMAGING
Today’s flow cytometric assays have the opportunity 
to clearly distinct between effector and target cells by 
using different mAb. For example effector cells can be 
labeled with mAB for CD3-CD16/56+ and  target cell 
with fluorescent dye such as CTO with light scattering 
characteristics such as FCS/SSC leading to cytotoxicity 
measurements in target cell with 7-AAD. Using large 
number of dyes simultaneously and own characteristics of 
cells, cells can be differentiated and evaluated (25,35).
Besides conduction of multiparametric evaluation of 
cells by using multi-purpose staining in flow cytometric 
assays, conjugated cells in addition to effector and target 
cells can be imaged clearly at single cell level (40,41). 
Moreover, assays measuring cell-mediated cytotoxicity in 
flow cytometry are being used and developed (accelerated) 
for other T-cells (γδ T cell) than NK or CTL (42,43).
Although clinical application area of these assays 
is not common today; the flow cytometric assays, in 
which multicolor and multivariate measurements can be 
Table I. Comparison of cell (NK) - mediated cytotoxicity assays.  
Assays Advantages Disadvantages References
I. Radioactive
CRA Golden standard Radioisotope 5,12,13
Simple test Expensive and short half-life
Repeatable results Spontaneous release
Measures necrosis Requires large and many cells
JAM Measures apoptosis Radioactive 14,15
Cheap
Easy, sensitive, and reliable
II. Non-radioactive Enzymatic assays





III. Non-radioactive Fluorescent Dyes 21-27
DiOC18, PKH, CAM Easy, sensitive, and reliable Membrane fixation 21-27
Leakage
Fluorogenic caspase Faster, more sensitive and reliable Does it reflect cell death? 38
Measurement at single cell level The effect of different stimuli?
FCM- mAb Single cell level Antibody specificity 28-30
Conjugation Dead cell marking difficulty
Easy and direct measurement Low fluorescent signal
Multi-parametric




Degranulation (mAb ) Easy Indirect measurement (real death?) 37
The effect of different stimuli?
NK: Natural killer, CRA: Chromium Release Assay, mAb: Monoclonal antibody, FCM: Flow cytometric, CMCA: Cell-mediated cytotoxicity assay
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performed at the same time, will gain importance in fields 
such as cancer immunotherapy (such as new clinical trials 
and measurement of immune response to cancer vaccines) 
or immune system diseases with impaired cytotoxicity in 
the near future.
CONCLUSION
Although radioactive assays measuring cytotoxicity 
do not lose their golden standard characteristics, flow 
cytometric assays using target and effector cell marker 
mAbs are prominent today.
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